ソニア・セラピューティクス株式会社

Sonire Therapeutics develops minimally invasive cancer treatment devices using high-intensity focused ultrasound (HIFU). Starting with pancreatic cancer, an intractable cancer, it aims to accelerate development of next-generation HIFU treatment devices and establish new treatment modalities in combination with medicines.